ORTEXORTEX News
Tracking TX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
TX
Earnings PreviewTX

Ternium Braces for Q3 Earnings as Options Caution Deepens

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 31 Oct 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Ternium S.A. reports Q3 results on November 3, and the options market has grown more defensive since the company's preliminary data release last week, while the stock has shed 5.7% over the past five days against a median gain of roughly 0.8% for its closest peers.

Options positioning is the clearest indicator of investor unease. The put/call ratio has risen to 0.48, more than 1.3 standard deviations above its 20-day average of 0.39. That gap has widened since the previous earnings preview: demand for downside protection is running above recent norms even as the raw number remains below 0.5, a reflection of how subdued call activity has been relative to the stock's history. Ternium closed at $52.77 on Thursday, down from $55.96 a week ago, extending its underperformance against steel and metals peers. STLD gained 3.8% over the same period, CLF added 2.5%, and AA rose 3.4%.

The short interest picture adds modest texture but is not the primary story. Short interest is just 0.25% of the free float, a low absolute level, though it has climbed 12% over the past week and 43% over the past month. The borrow market remains entirely relaxed: more than 10.7 million shares are available to borrow, dwarfing short positions of under 490,000 shares, with borrowing costs at 0.40%, less than half where they were a month ago.

Analyst sentiment has been broadly positive in 2026, with Morgan Stanley upgrading the stock to Overweight in August with a $65 target. Wells Fargo lifted its target to $56 this month while holding at Equal-Weight, and JP Morgan raised to $67.50 maintaining Overweight. The mean target of $61.50 implies roughly 16% upside from the current price. The valuation remains undemanding at 7.2 times trailing earnings and 4.6 times EV/EBITDA, with a price-to-book of 0.78. EPS momentum over 90 days ranks in the 87th percentile, and the earnings yield factor scores in the 78th.

The November 3 print will test whether Ternium's Latin American operations have delivered the margin profile that underpins those target prices, as the stock trades well below where most analysts have anchored their conviction.

Stocks in this article

See the live data behind this article on ORTEX.

Open TX on ORTEX →

How this article was generated

Generated
31 Oct 2026, 04:20
Data as of
31 Oct 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.